The Nomad Foods Podcast
In this episode of the Nomad Foods Podcast, Oliver Thomas sits down with Tom Wakeman, Insight Director at IGD, to unpack the rapid rise of GLP‑1 medications and their growing impact on the global food landscape. Tom explains what GLP‑1 drugs are, why adoption has accelerated, and how they’re already reshaping consumer behaviour - from calorie intake and snacking habits, to retailer choice and product innovation. Together, they explore the implications for retailers and manufacturers, the opportunities emerging across categories, and how organisations can respond thoughtfully to this long‑term shift in how people eat. To read more about the work IGD is doing in this space, please see here: https://www.igd.com/commercial-insight/glp-1 [https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.igd.com%2Fcommercial-insight%2Fglp-1&data=05%7C02%7CSean.Heary%40nomadfoods.com%7C0e30919d72c644a2747c08de7de3ddf1%7C2da4787e14194f44884cea6c7c5d19d3%7C0%7C0%7C639086614820690511%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=3aS0jEDlCXrWKHBufHkImtYhYwXdp29yEDIuQe21qWg%3D&reserved=0]
9 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der The Nomad Foods Podcast-Community!